Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma [Thoracic Oncology]
Conclusions
Hemithoracic IMPRINT for malignant pleural mesothelioma (MPM) is safe and has an acceptable rate of RP. Its incorporation with chemotherapy and P/D forms a new lung-sparing treatment paradigm for patients with locally advanced MPM.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Rimner, Zauderer, Gomez, Adusumilli, Parhar, Wu, Woo, Shen, Ginsberg, Yorke, Rice, Tsao, Rosenzweig, Rusch, Krug Tags: Radiation Oncology, Surgery, Radiation, Chemotherapy, Combined Modality Thoracic Oncology Source Type: research
More News: Alimta | Asbestosis | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Chemotherapy | Corticosteroid Therapy | Mesothelioma | Radiation Therapy | Study | Toxicology